双极射频阻抗控制子宫内膜消融联合左炔诺孕酮宫内缓释系统与单纯双极射频子宫内膜消融治疗异常子宫出血的比较
倾向性评分匹配研究纳入246例异常子宫出血患者,按1:1匹配后每组41例,比较NovaSure联合左炔诺孕酮宫内缓释系统(LNG-IUS)与单纯NovaSure的疗效。联合组在消融后6、12、24个月的闭经率和痛经缓解率均显著高于单纯组,12和24个月再干预率显著低于单纯组。作者认为联合方案在实现闭经、缓解痛经和减少再干预方面更有效。
要点
- 消融后6、12、24个月,联合组闭经率均显著高于单纯组(P<.005)。
- 消融后6、12、24个月,联合组痛经缓解率均显著高于单纯组。
- 消融后12和24个月,联合组再干预率显著低于单纯组。
核心结论
- 对于异常子宫出血女性,NovaSure子宫内膜消融联合LNG-IUS在实现闭经、缓解痛经和减少再干预方面比单纯NovaSure更有效。
研究设计与样本
- 倾向性评分匹配研究,纳入2013年1月至2016年8月在北京天坛医院接受NovaSure子宫内膜消融联合或不联合LNG-IUS的246例异常子宫出血患者,1:1匹配后每组41例。
主要发现
- 消融后6、12、24个月,联合组闭经率分别为78.05%、85.37%、87.80%,单纯组分别为46.34%、53.65%、58.54%(P<.005)。
- 消融后6、12、24个月,联合组痛经缓解率均为100%,单纯组分别为70.59%、64.70%、64.70%(P<.05、P<.01、P<.01)。
- 消融后6个月两组再干预率相似;消融后12和24个月,联合组再干预率分别为0和2.44%,单纯组分别为14.63%和21.95%(P<.05和P<.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: This study aims to evaluate the efficacy of the combination of bipolar radiofrequency impedance-controlled endometrial ablation (NovaSure; Hologic Inc., Bedford, MA) and levonorgestrel intrauterine system (LNG-IUS; Mirena; Schering AG, Berlin, Germany) placement in comparison with NovaSure endometrial ablation alone in patients with abnormal uterine bleeding (AUB). DESIGN: A propensity score matching study. SETTING: Beijing Tiantan Hospital, Capital Medical University, Beijing, China. PATIENTS: A retrospective study was conducted on 246 patients with AUB who underwent NovaSure endometrial ablation with (NovaSure+LNG-IUS group) or without (NovaSure group) LNG-IUS between January 2013 and August 2016. To overcome selection bias, propensity score matching was used to establish a 1:1 match between these 2 groups. Accordingly, 41 patients were included in each group. INTERVENTION: NovaSure endometrial ablation, immediately followed by LNG-IUS insertion in the NovaSure+LNG-IUS group, and NovaSure endometrial ablation alone in the control group. MEASUREMENTS AND MAIN RESULTS: Follow-up assessments performed at postablation months 6, 12, and 24 revealed the following: The rate of amenorrhea (78.05% vs 46.34%, 85.37% vs 53.65%, and 87.80% vs 58.54%, respectively; p <.005) and the rate of dysmenorrhea remission (100% vs 70.59%, 100% vs 64.70%, and 100% vs 64.70% [p <.05, p <.01, and p <.01], respectively) were significantly higher in the NovaSure+LNG-IUS group than in the NovaSure group. The rate of reinterventions was similar for both groups at postablation month 6. However, at postablation months 12 and 24, these rates were significantly lower in the NovaSure+LNG-IUS group than in the NovaSure group (0 vs 14.63% and 2.44% vs 21.95% [p <.05 and p <.01], respectively). CONCLUSION: For women with AUB, the combination of NovaSure endometrial ablation and LNG-IUS is more effective than NovaSure alone in achieving amenorrhea, alleviating dysmenorrhea and reducing reinterventions.
引用
- Zhao H, Yang B, Feng L, et al. Comparison of Combined Bipolar Radiofrequency Impedance-Controlled Endometrial Ablation with Levonorgestrel Intrauterine System versus Bipolar Radiofrequency Endometrial Ablation Alone in Women with Abnormal Uterine Bleeding. J Minim Invasive Gynecol. 2019. PMID: 31201942. doi:10.1016/j.jmig.2019.05.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。